$RXSF
MUST READ IT'S BIG
What if I told you there is a small public company that you can invest in where your investment could indirectly help save healthcare billions of dollars, as well as thousands of individual lives. What if I told you that company has and uses a similar technology that Apple and Samsung use to secure their phones and that technology is in products and are already available in the marketplace, protected by IP, yet the company flies under industry and investment radar like a stealth bomber ready to deliver its payload. And what if I told you that this investment can possibly provide you with huge returns. So let’s get this straight, a small public technology company, that can save lives and save healthcare billions of dollars annually, and you can make money? There must be a catch, right?
The name of the company is Rx Safes, Inc., out of Henderson Nevada, and trades under the symbol OTCQB:RXSF. What’s unique about this company is that it uses fingerprint technology to secure, and regulate the dispensing of controlled substances both in the home, healthcare facilities, as well as in medical devices. The company’s management team is credited with starting the consumer security biometrics market in the mid 2000’s and has previously developed products for Master Lock, Quickset, Honeywell, Overhead Door Company, SentrySafe, and has a record of selling 10’s of thousands of units through The Home Depot, Sears, Lowes, Sharper Image, Brookstone and hundreds of online retailers. Rx Safes, Inc’s founders have more than 30 years of combined experience in design, development, manufacturing, market and sales of fingerprint activated products, and since RxSafes formation in 2010, have focused their attention solely on using this technology to securely store and dispense controlled substances at the source, the end users.
And that’s huge in the world of healthcare. Just look at the numbers – drug diversion accounts for more than $180B annually in not only losses sustained through diverting controlled substances products from healthcare facilities, but also $140M in additional healthcare treatment costs because of resulting addiction, misuse and overdose. Also, more than 80,000 people a year die of drug overdose, and 70% of all drug addiction starts with teenaged kids stealing prescription drugs from parent’s medicine cabinets. Then add in the misuse of certain medical devices that dispense controlled substances such as infusion pumps and syringes, the entire social economic impact exceeds $600B annually. That’s $600 BILLION DOLLARS ANNUALLY. And the worst thing, there hasn’t been a company solely focused on preventing this in any meaningful way at the source until Rx Safes decided to apply its technology to fight this huge financial and personal epidemic.
RxSafes is on the precipice of having a tremendous impact on healthcare, for families, as well as multi-billion dollar medical facilities and systems. Each one of its products addresses separate multi-billion dollar sub markets within the healthcare industry, while also focusing on family safety.
Sounds really good, right? But not convinced yet? OK, lets look at some numbers – first the markets:
Consumers first – More than 80,000 people die each year directly attributable to drug abuse and overdose. So where does it start? 70% of all drug addiction starts when teenage kids access mom or dads prescription pain medications in the home medicine cabinet. More than 2500 teenagers a day between the ages of 12 and 17 try a prescription drug for the first time, mostly pain and tranquilizers such as oxycontin and lorezapam. These are known “gateway drugs” usually leading to heroin addiction. RxSafes manufactures a fingerprint activated home medication safe called the Rx DrugSAFE that can only be opened after it recognizes you. Yup, just like the iPHONE and GALAXY. Put your finger on the sensor, the product recognizes you, and you’re on your way, simply and securely. Who wouldn’t want to invest in a company that wants to get an Rx DrugSAFE in every one of the 245,000,000 homes in the USA? Well, you’re not alone. CVS has decided to offer to its customers Rx DrugSAFES at its website at CVS.com and has its eyes on a national in store offering in the near future. And that’s just the start. RxSafes has also recently put a program together to access more than $500M in state and local community grants designated solely to educate and combat drug addiction at the community level. In fact, Oklahoma is the first state to tap into those resources and purchased $50,000 worth of the Rx DrugSAFE from RxSAFES already. I expect dozens of other states to follow suit. And why not, there isn’t another product like it in the market.
Now the REAL business – professional healthcare. You may never heard of the term “drug diversion”, but trust me, healthcare professionals, pharmacies, state and federal government agencies have, and have targeted the problem of drug diversion in all areas of healthcare as a priority because it exponentially increases healthcare costs, that gets passed down to us, the end users of those services. Healthcare systems are devoting hundreds of millions of dollars in an effort to prevent drug diversion, and for RxSAFES, that comes down to one simple concept. Prevent drug diversion at its source. Rx SAFES products are focused just on that. For professional healthcare, it offers 2 paths – fingerprint secure lock-box safes and containers, and fingerprint controlled medical devices that are used directly to administer controlled substances. The company’s professional grade fingerprint lock-boxes are designed for healthcare facilities with greater capacity than the consumer home version, but is made of the exact same materials. Then, there are the 2 initial medical devices, a fingerprint activated PCA infusion pump switch, and a fingerprint activated reusable needleless injector system. While the fingerprint lock boxes prevent direct access by unauthorized personal, the medical devices are truly unique. The infusion pump market is a $7 billion annual market, with its current PCA switches (called pendants) accounting for most of those annual sales because their useful life is only 12 months, and constantly need replacing. The BIG issue here, is that ANYONE, can walk up to a patient hooked up to an infusion pump, and press a button, and administer MORE medication to the patient – and the issue has now become PCA by Proxy (a third party providing MORE medication to the patient through a patient controlled analgesia switch). WOW, common sense dictates that this switch needs to be secured, as more and more instances of overdose and death by PCA by Proxy are being reported by healthcare systems, even the pump manufacturers Baxter, CareFusion, Smiths Medical and Abbott, all potential clients and partners for Rx SAFES, understand this problem and ALL are seeking solutions, they just don’t realize yet it exists, but they will. The biggest culprits to drug diversion are syringes. More pain medications, morphine, methadone, etc…are dispensed through injection than by any other way. And who can inject? Actually, anyone can operate a syringe, and by its design, it is NOT secure. Now imagine a reusable, painless, needleless “jet injector” (yea, Star Trek rings a bell) that can only be activated when the injector recognizes you as an authorized user. Just like your iPHONE and GALAXY, it will only operate after it recognizes you through your fingerscan.
Now, ask yourself this question, APPLE and SAMSUNG have made a market decision to offer this technology in their products as a security feature initially, but now numerous additional uses are found for the fingerprint scanner, such as point of sale transactions. Why, because it not only works, but more people feel safer with it than without it. So why not apply the use of this technology to solve multi-billion dollar issues in healthcare. RxSAFES recognized this years ago and is doing just that.
Now for the good part – the company only has 1,400,000 shares issued and outstanding and its public float is somewhere in the neighborhood of 250,000. THAT’S IT. And it’s trading around $1.50 reflecting a seriously undervalued market cap of around $2M. It just up-listed to the OTCQB and it plans on shedding its convertible debt (about $300K) through traditional financing and it has an experienced proven management team that knows the biometrics market better than most of the other company’s on bigger national exchanges. It just went through a corporate stock restructuring effectuating a reverse split of 1 for 200 a month ago, and it’s up 25% (unheard of on the OTC). No one knows about this company other than a few press releases and a small contingency of loyal, long shareholders and insiders that continue to buy up some of the float in the market. The CEO is transparent, providing regular shareholder updates that include its intentions to applying to NASDAQ or the NYSE MTK exchanges in the near future.
So in the end, investors can help this company and themselves. The more this company improves its share price, the less dilutive money it attracts, and that money is used to put these products into the marketplace, generate revenues and bring more attention to the company and its products. RxSAFES is one of those hidden gems in a turbulent sea. The more positive attention we can bring to the investment community about this hidden gem, the more good the company can do for families and the healthcare markets. And in the end, the more money we can make.
As always, these are my opinions based on my own due diligence, but I suggest you take a good look at this company, starting with its website at www.rxdrugsafe.com, then look at its disclosures, filings, press releases and shareholder updates and make your own informed decisions. I’m long and I have personal experiences with addiction and that’s why I KNOW this will be a huge success story.
Sincerely
Robert C
A Devoted Investor
MUST READ IT'S BIG
What if I told you there is a small public company that you can invest in where your investment could indirectly help save healthcare billions of dollars, as well as thousands of individual lives. What if I told you that company has and uses a similar technology that Apple and Samsung use to secure their phones and that technology is in products and are already available in the marketplace, protected by IP, yet the company flies under industry and investment radar like a stealth bomber ready to deliver its payload. And what if I told you that this investment can possibly provide you with huge returns. So let’s get this straight, a small public technology company, that can save lives and save healthcare billions of dollars annually, and you can make money? There must be a catch, right?
The name of the company is Rx Safes, Inc., out of Henderson Nevada, and trades under the symbol OTCQB:RXSF. What’s unique about this company is that it uses fingerprint technology to secure, and regulate the dispensing of controlled substances both in the home, healthcare facilities, as well as in medical devices. The company’s management team is credited with starting the consumer security biometrics market in the mid 2000’s and has previously developed products for Master Lock, Quickset, Honeywell, Overhead Door Company, SentrySafe, and has a record of selling 10’s of thousands of units through The Home Depot, Sears, Lowes, Sharper Image, Brookstone and hundreds of online retailers. Rx Safes, Inc’s founders have more than 30 years of combined experience in design, development, manufacturing, market and sales of fingerprint activated products, and since RxSafes formation in 2010, have focused their attention solely on using this technology to securely store and dispense controlled substances at the source, the end users.
And that’s huge in the world of healthcare. Just look at the numbers – drug diversion accounts for more than $180B annually in not only losses sustained through diverting controlled substances products from healthcare facilities, but also $140M in additional healthcare treatment costs because of resulting addiction, misuse and overdose. Also, more than 80,000 people a year die of drug overdose, and 70% of all drug addiction starts with teenaged kids stealing prescription drugs from parent’s medicine cabinets. Then add in the misuse of certain medical devices that dispense controlled substances such as infusion pumps and syringes, the entire social economic impact exceeds $600B annually. That’s $600 BILLION DOLLARS ANNUALLY. And the worst thing, there hasn’t been a company solely focused on preventing this in any meaningful way at the source until Rx Safes decided to apply its technology to fight this huge financial and personal epidemic.
RxSafes is on the precipice of having a tremendous impact on healthcare, for families, as well as multi-billion dollar medical facilities and systems. Each one of its products addresses separate multi-billion dollar sub markets within the healthcare industry, while also focusing on family safety.
Sounds really good, right? But not convinced yet? OK, lets look at some numbers – first the markets:
Consumers first – More than 80,000 people die each year directly attributable to drug abuse and overdose. So where does it start? 70% of all drug addiction starts when teenage kids access mom or dads prescription pain medications in the home medicine cabinet. More than 2500 teenagers a day between the ages of 12 and 17 try a prescription drug for the first time, mostly pain and tranquilizers such as oxycontin and lorezapam. These are known “gateway drugs” usually leading to heroin addiction. RxSafes manufactures a fingerprint activated home medication safe called the Rx DrugSAFE that can only be opened after it recognizes you. Yup, just like the iPHONE and GALAXY. Put your finger on the sensor, the product recognizes you, and you’re on your way, simply and securely. Who wouldn’t want to invest in a company that wants to get an Rx DrugSAFE in every one of the 245,000,000 homes in the USA? Well, you’re not alone. CVS has decided to offer to its customers Rx DrugSAFES at its website at CVS.com and has its eyes on a national in store offering in the near future. And that’s just the start. RxSafes has also recently put a program together to access more than $500M in state and local community grants designated solely to educate and combat drug addiction at the community level. In fact, Oklahoma is the first state to tap into those resources and purchased $50,000 worth of the Rx DrugSAFE from RxSAFES already. I expect dozens of other states to follow suit. And why not, there isn’t another product like it in the market.
Now the REAL business – professional healthcare. You may never heard of the term “drug diversion”, but trust me, healthcare professionals, pharmacies, state and federal government agencies have, and have targeted the problem of drug diversion in all areas of healthcare as a priority because it exponentially increases healthcare costs, that gets passed down to us, the end users of those services. Healthcare systems are devoting hundreds of millions of dollars in an effort to prevent drug diversion, and for RxSAFES, that comes down to one simple concept. Prevent drug diversion at its source. Rx SAFES products are focused just on that. For professional healthcare, it offers 2 paths – fingerprint secure lock-box safes and containers, and fingerprint controlled medical devices that are used directly to administer controlled substances. The company’s professional grade fingerprint lock-boxes are designed for healthcare facilities with greater capacity than the consumer home version, but is made of the exact same materials. Then, there are the 2 initial medical devices, a fingerprint activated PCA infusion pump switch, and a fingerprint activated reusable needleless injector system. While the fingerprint lock boxes prevent direct access by unauthorized personal, the medical devices are truly unique. The infusion pump market is a $7 billion annual market, with its current PCA switches (called pendants) accounting for most of those annual sales because their useful life is only 12 months, and constantly need replacing. The BIG issue here, is that ANYONE, can walk up to a patient hooked up to an infusion pump, and press a button, and administer MORE medication to the patient – and the issue has now become PCA by Proxy (a third party providing MORE medication to the patient through a patient controlled analgesia switch). WOW, common sense dictates that this switch needs to be secured, as more and more instances of overdose and death by PCA by Proxy are being reported by healthcare systems, even the pump manufacturers Baxter, CareFusion, Smiths Medical and Abbott, all potential clients and partners for Rx SAFES, understand this problem and ALL are seeking solutions, they just don’t realize yet it exists, but they will. The biggest culprits to drug diversion are syringes. More pain medications, morphine, methadone, etc…are dispensed through injection than by any other way. And who can inject? Actually, anyone can operate a syringe, and by its design, it is NOT secure. Now imagine a reusable, painless, needleless “jet injector” (yea, Star Trek rings a bell) that can only be activated when the injector recognizes you as an authorized user. Just like your iPHONE and GALAXY, it will only operate after it recognizes you through your fingerscan.
Now, ask yourself this question, APPLE and SAMSUNG have made a market decision to offer this technology in their products as a security feature initially, but now numerous additional uses are found for the fingerprint scanner, such as point of sale transactions. Why, because it not only works, but more people feel safer with it than without it. So why not apply the use of this technology to solve multi-billion dollar issues in healthcare. RxSAFES recognized this years ago and is doing just that.
Now for the good part – the company only has 1,400,000 shares issued and outstanding and its public float is somewhere in the neighborhood of 250,000. THAT’S IT. And it’s trading around $1.50 reflecting a seriously undervalued market cap of around $2M. It just up-listed to the OTCQB and it plans on shedding its convertible debt (about $300K) through traditional financing and it has an experienced proven management team that knows the biometrics market better than most of the other company’s on bigger national exchanges. It just went through a corporate stock restructuring effectuating a reverse split of 1 for 200 a month ago, and it’s up 25% (unheard of on the OTC). No one knows about this company other than a few press releases and a small contingency of loyal, long shareholders and insiders that continue to buy up some of the float in the market. The CEO is transparent, providing regular shareholder updates that include its intentions to applying to NASDAQ or the NYSE MTK exchanges in the near future.
So in the end, investors can help this company and themselves. The more this company improves its share price, the less dilutive money it attracts, and that money is used to put these products into the marketplace, generate revenues and bring more attention to the company and its products. RxSAFES is one of those hidden gems in a turbulent sea. The more positive attention we can bring to the investment community about this hidden gem, the more good the company can do for families and the healthcare markets. And in the end, the more money we can make.
As always, these are my opinions based on my own due diligence, but I suggest you take a good look at this company, starting with its website at www.rxdrugsafe.com, then look at its disclosures, filings, press releases and shareholder updates and make your own informed decisions. I’m long and I have personal experiences with addiction and that’s why I KNOW this will be a huge success story.
Sincerely
Robert C
A Devoted Investor
